MeSH D020820 - dyskinesias
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D020820:
Dyskinesias
D001259:Ataxia
0 Companies
0 Drugs
Success rate
D001264:Athetosis
0 Companies
0 Drugs
Success rate
D002375:Catalepsy
0 Companies
0 Drugs
Success rate
D004409:Drug-induced dyskinesia
D004421:Dystonia
D006948:Hyperkinesis
D009207:Myoclonus
0 Companies
0 Drugs
Success rate
D011595:Psychomotor agitation
D014202:Tremor
D018476:Hypokinesia
0 Companies
0 Drugs
Success rate
D020323:Tics
0 Companies
0 Drugs
Success rate
D046608:Synkinesis
0 Companies
0 Drugs
Success rate
Events Timeline
Commercial
No Data
Clinical Trials
Historical Success Rate
Phase 1
50%1/2
Phase 2
24%4/17
Phase 3
45%5/11
Approved: 3Overall Success rate: 5%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
4
>
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use